Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases

NCT07184450 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Juvenile Dermatomyositis (JDM)
Polyarticular Juvenile Idiopathic Arthritis
Systemic Sclerosis (SSc)
Primary Sjogren's Syndrome

Interventions

BIOLOGICAL: BCMA/CD70-targetd CAR-T

Sponsor

Chongqing Precision Biotech Co., Ltd